MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-50-0013439
Nakularch Meditech Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.9 Cr
▲ 1% YoY
Net profit · FY 2025
₹33.56 Lakh
Net margin 4.9%
EBITDA · FY 2025
₹54.74 Lakh
EBITDA margin 7.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹35 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
About Nakularch Meditech Private Limited
Data last updated:
Nakularch Meditech Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2017PTC093303. Its GSTIN is 09AAFCN6357B1ZG (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Nakularch Meditech (Opc) Private Limited. It is led by directors including Kuldeep Singh and Deepika.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 5/47 Avas Vikas Amrapali Yojana Hardoi Road, Lucknow, Uttar Pradesh, India – 226003.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.9 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹33.56 Lakh (net margin 4.9%) and EBITDA of ₹54.74 Lakh (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹35 Lakh on record.
Nakularch Meditech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0013439). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nakularch.com.
Company Details of Nakularch Meditech Private Limited
CIN U74999UP2017PTC093303
Registration Number 093303
Incorporation Date 19 May 2017
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-50-0013439
CIN History of Nakularch Meditech Private Limited
Nakularch Meditech has one previous CIN (Corporate Identification Number): U74999UP2017OPC093303. The current CIN is U74999UP2017PTC093303, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999UP2017PTC093303 | Current |
| U74999UP2017OPC093303 | Previous |
Recognitions & Rankings of Nakularch Meditech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressE – 5/47 Avas Vikas Amrapali Yojana Hardoi Road, Lucknow, Uttar Pradesh, India – 226003
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Nakularch Meditech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Nakularch Meditech Private Limited
The main business activity of Nakularch Meditech is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nakularch Meditech Private Limited FY 2025 filings available
Nakularch Meditech Private Limited reported revenue of ₹6.9 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹6.9 Cr ▲ 1%
Net profit · FY 2025
₹33.56 Lakh margin 4.9%
EBITDA · FY 2025
₹54.74 Lakh margin 7.9%
Compounded Annual Growth Rate (CAGR) of Nakularch Meditech Private Limited
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 2%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 20%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 1% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nakularch Meditech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹54.74 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nakularch Meditech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nakularch Meditech are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nakularch Meditech Private Limited
Nakularch Meditech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naval Kishore Also directs: LCH & Research Center Private Limited, LCH Medicos Private Limited | Nominee | 19 May 2017 | 9 Years 5 Months | Current |
| Kuldeep Singh | Director | 19 May 2017 | 9 Years 5 Months | Current |
| Deepika Also directs: Nakularch Hospitals Private Limited | Director | 12 Jun 2021 | 5 Years 4 Months | Current |
Peer Comparison of Nakularch Meditech Private Limited
Nakularch Meditech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vulcan Laboratories Pvt Ltd | ₹6.93 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Kolkata, West Bengal, India |
| Spab Chemicals Private Limited | ₹6.93 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Mumbai, Maharashtra, India |
| SK Formulations India Private Limited | ₹6.92 Cr (FY 2023) | •••• | •••• | 23.0% | •••• | Thane, Maharashtra, India |
| Maxell Pharma Private Limited | ₹6.92 Cr (FY 2024) | •••• | •••• | 52.0% | •••• | Sriperumbudur, Tamil Nadu, India |
| Graviton Life Care Private Limited | ₹6.9 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Ahmednagar, Maharashtra, India |
| Nakularch Meditech Private Limited this company | ₹6.9 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Lucknow, Uttar Pradesh, India |
| Vikram Laboratories Private Limited | ₹6.9 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Uttar Pradesh, India |
| Vivifi Life Sciences Private Limited | ₹6.89 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Thiruvananthapuram, Kerala, India |
| Megha Healthcare Private Limited | ₹6.88 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Quality Nexgen Pharmaceuticals Private Limited | ₹6.88 Cr (FY 2022) | •••• | •••• | -42.0% | •••• | Mumbai, Maharashtra, India |
| Ikem Pharma Private Limited | ₹6.87 Cr (FY 2024) | •••• | •••• | -62.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Nakularch Meditech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nakularch Meditech Private Limited
Nakularch Meditech Private Limited is audited by Batra Sapra & Company for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Batra Sapra & Company | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nakularch Meditech Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nakularch Meditech Private Limited
Open charges
₹35 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2021 | Hdfc Bank Limited | ₹35 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Nakularch Meditech Private Limited
Employment history and EPFO contributions of people linked to Nakularch Meditech.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nakularch Meditech Private Limited
Nakularch Meditech Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Abrar Ahmad ceased to be Director on 05 Aug 2025.
AGM
Nakularch Meditech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Abrar Ahmad ceased to be Director.
Ceased
Amarjeet Verma ceased to be Director.
Filing
Nakularch Meditech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Deepika was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 35.00 Lakh with Charge ID 100427512 was registered on 25 Feb 2021.
Appointed
Kuldeep Singh was appointed as Director.
Appointed
Naval Kishore was appointed as Nominee.
Incorporation
19 May 2017
Nakularch Meditech Private Limited was registered on 19 May 2017 with Roc Kanpur & aged 9 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Nakularch Meditech Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nakularch Meditech Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nakularch Meditech Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nakularch Meditech Private Limited
Nakularch Meditech has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN6357B1ZG | Uttar Pradesh | Active | 23 Jul 2017 |
| 06AAFCN6357B1ZM | Haryana | Active | 21 Feb 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nakularch Meditech Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nakularch Meditech Private Limited
Nakularch Meditech is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 May 2017 (9+ years old) and is registered under CIN U74999UP2017PTC093303.
Nakularch Meditech reported revenue of ₹6.9 Cr for FY 2025 (up 1% YoY).
Nakularch Meditech has 3 current directors:
- Kuldeep Singh - Director
- Deepika - Director
- Naval Kishore - Nominee
Nakularch Meditech reported a net profit of ₹33.56 Lakh (net margin 4.9%) and EBITDA of ₹54.74 Lakh (EBITDA margin 7.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nakularch Meditech is 2% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nakularch Meditech is 09AAFCN6357B1ZG, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAFCN6357B1ZM (Haryana).
The CIN (Corporate Identification Number) of Nakularch Meditech is U74999UP2017PTC093303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nakularch Meditech was incorporated on 19 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Nakularch Meditech by revenue are Vulcan Laboratories Pvt Ltd, Spab Chemicals Private Limited, SK Formulations India Private Limited, Maxell Pharma Private Limited, Graviton Life Care Private Limited and 5 more, all in the Pharma industry (Formulations).
Abrar Ahmad ceased to be Director on 05 Aug 2025. Amarjeet Verma ceased to be Director on 05 Aug 2025. Deepika was appointed as Director on 12 Jun 2021. Nakularch Meditech has 5 board changes on record in total.
Yes, Nakularch Meditech is registered as a small enterprise under Udyam registration (number: UDYAM-UP-50-0013439).